Averto Medical raised $30.5M in a series A financing led by Cormorant Asset Management to advance ColoSeal™ Intraluminal Diversion System for clinical testing and regulatory approvals.
Averto Medical raised $30.5M in a series A financing led by Cormorant Asset Management to advance ColoSeal™ Intraluminal Diversion System for clinical testing and regulatory approvals.
05/07/24, 12:54 PM
Location
fremontMoney raised
$30.5 million
Industry
medical device
medical
biotechnology
health care
Round Type
series a
Investors
Cvf, Life Sci Venture Partners, Venrock Healthcare Capital Partners, Cormorant Asset Management
Averto Medical closed an oversubscribed $30.5 million series A financing led by Cormorant Asset Management with participation from Venrock Healthcare Capital Partners, LifeSci Venture Partners, CVF, and other investors. The funding will support advancing Averto Medical's clinical testing of the ColoSeal™ Intraluminal Diversion System towards regulatory approvals, targeting a multi-billion dollar market opportunity.